Compass Pathways Teams Up with Osmind to Prepare Clinics for Psychedelic Care Compass Pathways plc, a biotechnology company focused on expanding access to evidence-based mental health innovations, has announced a strategic collaboration with Osmind, a platform that supports a large…
ModMed Buys Bonsai Health to Advance AI Patient Engagement ModMed, a prominent provider of technology solutions for specialty medical practices, has announced the acquisition of Bonsai Health, an emerging leader in agentic AI-powered patient engagement. This strategic move represents a…
HCA Healthcare Lands 29 Hospitals on Modern Healthcare’s Top 100 List HCA Healthcare has announced that 29 of its hospitals have earned recognition as top-performing facilities in the 2026 edition of the “100 Top Hospitals,” a prestigious list compiled by…
Cigna Foundation Offers $250K in Grants to Memphis Nonprofits to Expand Health Care Access The The Cigna Group Foundation has announced a significant expansion of its Impact Fund to Memphis, reinforcing its long-standing commitment to improving community health outcomes across…
UnitedHealthcare Eases Prior Authorizations, Speeds Payments for Rural Providers Nationwide UnitedHealthcare has unveiled a sweeping expansion of its rural health care strategy, introducing a set of nationwide initiatives aimed at strengthening independent rural hospitals, easing administrative burdens, and improving access…
Secondary Offering of 3.1M Shares Priced at $3.25 Each by Selling Stockholder SBC Medical Group Holdings Incorporated has announced the pricing of an underwritten secondary public offering involving 3.1 million shares of its common stock. The transaction, disclosed in an…
Synthetic Design Lab Debuts First Logic-Gated ADC at AACR 2026, Showing Over 10X Boost in Cancer Cell Killing Synthetic Design Lab has unveiled a bold new direction in the field of biologic therapeutics with the introduction of its SYNTHBODY™ platform—a…
Lundbeck Shares AAN 2026 Data Showing Real-World Cognitive Improvements in Migraine Patients Treated with VYEPTI Lundbeck today presented new real-world 6-month results from the INFUSE study at the American Academy of Neurology (AAN) 2026 Annual Meeting, underscoring the importance of evaluating the…
Definium Therapeutics Supports White House Order to Advance Psychedelic Mental Health Treatments Definium Therapeutics a late-stage clinical biopharmaceutical company focused on addressing the root causes of psychiatric and neurological disorders, has publicly expressed its support for a newly signed White…
Inocras & Broad Institute Unveil New TCGA Whole-Genome Insights to Advance Cancer Genomics Researchers from Inocras and the Broad Institute of MIT and Harvard are set to unveil significant new findings from one of the most extensive whole-genome cancer analyses…
Compass Pathways Backs White House Initiative to Accelerate Psychedelic Treatments for Mental Health Compass Pathways plc a biotechnology company focused on expanding access to evidence-based mental health innovations, has expressed strong support for a recent White House Executive Order aimed…
HSS Research Highlights AI’s Growing Role in Predicting Pain Risk and Improving Anesthesia Education At the American Society of Regional Anesthesia and Acute Pain Medicine (ASRA) annual meeting, researchers from Hospital for Special Surgery (HSS) unveiled new findings demonstrating how…